PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
D000970:Antineoplastic Agents; D004358:Drug Therapy; D006689:Hodgkin Disease; D006918:Hydroxyurea; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D009369:Neoplasms / Q000453:epidemiology*; D012509:Sarcoma; D014508:Urea
D000970:Antineoplastic Agents; D014508:Urea; D006918:Hydroxyurea
ANTINEOPLASTIC AGENTS; DRUG THERAPY; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; NEOPLASM STATISTICS; SARCOMA; UREA